Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening.
Francesco IzzoMeredith C MasonEric J SilberfeinNader N MassarwehCary HsuHop S Tran CaoRaffaele PalaiaMauro PiccirilloAndrea BelliRenato PatroneRoberta FuscoVincenza GranataSteven A CurleyPublished in: Biology (2022)
Our screening program diagnosed early-stage HCC, permitting curative-intent treatment in 70%, but the 10-year survival rate is 4% due to HCC recurrence and progressive cirrhosis.